期刊文献+

固本生血丸治疗慢性再生障碍性贫血的临床与药理研究

Clinical and Pharmacological Studies the Treatment of Chronic Aplastic Anemia with“Guben Shengxue Wan”
全文增补中
导出
摘要 用中药制剂固本生血丸加康力龙等西药治疗慢性再生障碍性贫血30例,与单用康力龙等西药组进行对照、疗效明显优于对照组,2组同时进行抗马利兰诱发小鼠骨髓造血障碍作用试验,治疗组在降低死亡率及降低骨髓造血障碍发生率方面明显优于对照组。 Thirty patients with chronic aplastic anemia were treated with the prescription ofChinese medicines,' Guben Shengxue Wan' in combination with stanozolol.The curative effectwas superior to that of the patients treated with stanozolol alone. The experiment of anti-myler- an-induced hematopoietic disorder of bone marrow was carried out simultaneously in the two pa- tient groups. The result of the former patient group was superior in decreasing mortality andlowering incidence of hematopoietic disorder to that of the latter.
出处 《中国实验方剂学杂志》 CAS 1996年第5期31-34,共4页 Chinese Journal of Experimental Traditional Medical Formulae
关键词 再生障碍性贫血 固本生血丸 中医药结合治疗 Chronic Aplastic Anemia, Guben shengxue wan,Pharmacological text
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部